What is it about?

The European Society of Gastroenterology, Hepatology and nutrition updated its guidelines for diagnosis of coeliac disease in 2020 adopting a non-biopsy approach if coeliac disease serology (TGA-IgA) was elevated more than 10 times the upper normal limit and endomysial antibodies (EMA) were positive in a second serum sample. However, EMA is expensive and not readily available in many regions of the world, Which raised the question: Can we diagnose coeliac disease based on TGA-IgA alone?

Featured Image

Why is it important?

Elevated TGA-IgA levels are common at diagnosis of T1D and do not consistently predict CD. Our data support repeating serology and pursuing biopsy in those with persistent elevation of TGA-IgA to avoid overdiagnosis of CD in children with newly diagnosed

Read the Original

This page is a summary of: Diagnostic Outcomes of Elevated Transglutaminase IgA Antibodies in Children With Newly Diagnosed Type 1 Diabetes, Diabetes Care, December 2024, American Diabetes Association,
DOI: 10.2337/dc24-1554.
You can read the full text:

Read

Contributors

The following have contributed to this page